Precision-guided, personalized intrapleural fibrinolytic therapy for empyema and complicated parapneumonic pleural effusions: The case for the fibrinolytic potential by Idell, S, Florova, G, Shetty, S, Tucker, T, Idell, R, Koenig, K, Azghani, A, Rahman, N, Komissarov, A

Fibrin turnover and organization of pleural injury: Bench to bedside by Komissarov, A, Rahman, N, Lee, Y, Florova, G, Shetty, S, Idell, R, Ikebe, M, Das, K, Tucker, T, Idell, S

Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models by Komissarov, A, Florova, G, Azghani, A, Buchanan, A, Boren, J, Allen, T, Rahman, N, Koenig, K, Chamiso, M, Karandashova, S, Henry, J, Idell, S

Phase 1b Trial of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) o... by Idell, S, Beckert, L, Brockway, B, Simpson, G, Southcott, A, Lee, Y, Rahman, N, Light, R, Shoemaker, S, Gillies, J, Komissarov, A, Florova, G, Sarva, K

Intrapleural and plasma processing of LTI-01 (single chain urokinase Plasminogen Activator, scuPA) in a phase 1b trial of LTI-01 Intrapleural Fibrinolytic Therapy (IPFT) in patient... by Komissarov, A, Florova, G, Beckert, L, Brockway, B, Simpson, G, Southcott, A, Lee, Y, Rahman, N, Light, R, Shoemaker, S, Gillies, J, Sarva, K, Idell, S

Phase I trial of the single-chain urokinase intrapleural LTI-01 in complicated parapneumonic effusions or empyema by Beckert, L, Brockway, B, Simpson, G, Southcott, A, Lee, Y, Rahman, N, Light, R, Shoemaker, S, Gillies, J, Komissarov, A, Florova, G, Ochran, T, Bradley, W, Ndetan, H, Singh, K, Sarva, K, Idell, S